Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion
Abstract Background/aims Mesenchymal stem cells (MSCs) have shown promising therapeutic potential in treating liver diseases, such as non-alcoholic fatty liver disease (NAFLD). Genetic modification has been employed to enhance the characteristics of MSCs for more effective disease treatment. Here, w...
Saved in:
| Main Authors: | Caifeng Zhang, Juanjuan Ji, Xuefang Du, Lanfang Zhang, Yaxuan Song, Yuyu Wang, Yanan Jiang, Ke Li, Tingmin Chang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Cell Communication and Signaling |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-024-01950-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ATG5 and ATG7 Expression Levels Are Reduced in Cutaneous Melanoma and Regulated by NRF1
by: Živa Frangež, et al.
Published: (2021-08-01) -
Corrigendum: ATG5 and ATG7 expression levels are reduced in cutaneous melanoma and regulated by NRF1
by: Živa Frangež, et al.
Published: (2025-01-01) -
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin
by: Itai Falicovich, et al.
Published: (2025-01-01) -
Tetrahymena ATG8 homologs, TtATG8A and TtATG8B, are responsible for mitochondrial degradation induced by starvation
by: Shinya Matsuda, et al.
Published: (2025-06-01) -
A review shows that ATG10 has been identified as a potential prognostic marker and therapeutic target for cancer patients based on real-world studies
by: Ke Shi, et al.
Published: (2025-04-01)